Linked Life Data

17488293

Source:http://linkedlifedata.com/resource/pubmed/id/17488293

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17488293rdf:typepubmed:Citationlld:pubmed
pubmed-article:17488293lifeskim:mentionsumls-concept:C0027651lld:lifeskim
pubmed-article:17488293lifeskim:mentionsumls-concept:C0011306lld:lifeskim
pubmed-article:17488293lifeskim:mentionsumls-concept:C0441889lld:lifeskim
pubmed-article:17488293lifeskim:mentionsumls-concept:C0018270lld:lifeskim
pubmed-article:17488293lifeskim:mentionsumls-concept:C1539081lld:lifeskim
pubmed-article:17488293lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:17488293lifeskim:mentionsumls-concept:C0684321lld:lifeskim
pubmed-article:17488293lifeskim:mentionsumls-concept:C1609990lld:lifeskim
pubmed-article:17488293lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:17488293lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:17488293pubmed:issue1lld:pubmed
pubmed-article:17488293pubmed:dateCreated2007-6-12lld:pubmed
pubmed-article:17488293pubmed:abstractTextTumour regression requires activation of T cells. It has been shown that the interaction between T cell-expressed CD40-ligand (CD40-L) and antigen-presenting cell-expressed CD40 plays a crucial role in T cell activation. CD40-L- or CD40-deficient mice are susceptible to tumour growth. CD40-based therapies are also shown to control tumour growth significantly, suggesting that CD40-CD40-L interaction induces anti-tumour T cell responses and tumour regression. We demonstrate that the anti-tumour T cell response can be modulated reciprocally as a function of the levels of CD40 expression. At low expression levels, CD40 promotes tumour growth; at higher expression levels, CD40 induces tumour-regressing T cell response. Dendritic cells (DC) sorted onto major histocompatibility complex (MHC)-II expression are found to be similar in CD40 and CD80 expression. The MHC-II(hi)/CD40(hi) DC induce interleukin (IL)-12-dominated and T helper 1 (Th1)-type response, whereas MHC-II(lo)/CD40(lo) DC promote high IL-10 and Th2-type T cells. The T cells induced by these DC also differ in terms of regulatory T cell markers, lymphocyte activation gene-3 (LAG-3) and glucocorticoid-induced tumour necrosis factor (TNF) receptor family-related gene (GITR). Thus, we report for the first time that CD40-induced effector T cell response depends on CD40 expression levels in vivo.lld:pubmed
pubmed-article:17488293pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488293pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488293pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488293pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488293pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488293pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488293pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488293pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488293pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488293pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488293pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488293pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488293pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488293pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488293pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488293pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488293pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488293pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488293pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488293pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488293pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488293pubmed:languageenglld:pubmed
pubmed-article:17488293pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488293pubmed:citationSubsetIMlld:pubmed
pubmed-article:17488293pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488293pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488293pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488293pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488293pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488293pubmed:statusMEDLINElld:pubmed
pubmed-article:17488293pubmed:monthJullld:pubmed
pubmed-article:17488293pubmed:issn0009-9104lld:pubmed
pubmed-article:17488293pubmed:authorpubmed-author:MartinSSlld:pubmed
pubmed-article:17488293pubmed:authorpubmed-author:SahiJJlld:pubmed
pubmed-article:17488293pubmed:authorpubmed-author:MurugaiyanGGlld:pubmed
pubmed-article:17488293pubmed:issnTypePrintlld:pubmed
pubmed-article:17488293pubmed:volume149lld:pubmed
pubmed-article:17488293pubmed:ownerNLMlld:pubmed
pubmed-article:17488293pubmed:authorsCompleteYlld:pubmed
pubmed-article:17488293pubmed:pagination194-202lld:pubmed
pubmed-article:17488293pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:17488293pubmed:meshHeadingpubmed-meshheading:17488293...lld:pubmed
pubmed-article:17488293pubmed:meshHeadingpubmed-meshheading:17488293...lld:pubmed
pubmed-article:17488293pubmed:meshHeadingpubmed-meshheading:17488293...lld:pubmed
pubmed-article:17488293pubmed:meshHeadingpubmed-meshheading:17488293...lld:pubmed
pubmed-article:17488293pubmed:meshHeadingpubmed-meshheading:17488293...lld:pubmed
pubmed-article:17488293pubmed:meshHeadingpubmed-meshheading:17488293...lld:pubmed
pubmed-article:17488293pubmed:meshHeadingpubmed-meshheading:17488293...lld:pubmed
pubmed-article:17488293pubmed:meshHeadingpubmed-meshheading:17488293...lld:pubmed
pubmed-article:17488293pubmed:meshHeadingpubmed-meshheading:17488293...lld:pubmed
pubmed-article:17488293pubmed:meshHeadingpubmed-meshheading:17488293...lld:pubmed
pubmed-article:17488293pubmed:meshHeadingpubmed-meshheading:17488293...lld:pubmed
pubmed-article:17488293pubmed:meshHeadingpubmed-meshheading:17488293...lld:pubmed
pubmed-article:17488293pubmed:meshHeadingpubmed-meshheading:17488293...lld:pubmed
pubmed-article:17488293pubmed:meshHeadingpubmed-meshheading:17488293...lld:pubmed
pubmed-article:17488293pubmed:meshHeadingpubmed-meshheading:17488293...lld:pubmed
pubmed-article:17488293pubmed:meshHeadingpubmed-meshheading:17488293...lld:pubmed
pubmed-article:17488293pubmed:meshHeadingpubmed-meshheading:17488293...lld:pubmed
pubmed-article:17488293pubmed:year2007lld:pubmed
pubmed-article:17488293pubmed:articleTitleLevels of CD40 expression on dendritic cells dictate tumour growth or regression.lld:pubmed
pubmed-article:17488293pubmed:affiliationNational Centre for Cell Science, Ganeshkhind, Pune, India.lld:pubmed
pubmed-article:17488293pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17488293pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:21939entrezgene:pubmedpubmed-article:17488293lld:entrezgene